Elicio Therapeutics Reports Officer and Director Changes
Ticker: ELTX · Form: 8-K · Filed: Mar 24, 2025 · CIK: 1601485
| Field | Detail |
|---|---|
| Company | Elicio Therapeutics, Inc. (ELTX) |
| Form Type | 8-K |
| Filed Date | Mar 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, corporate-governance
Related Tickers: ELIO
TL;DR
Elicio Therapeutics (ELIO) filed an 8-K detailing changes to its board and officers effective March 21st.
AI Summary
Elicio Therapeutics, Inc. filed an 8-K on March 24, 2025, reporting changes effective March 21, 2025. The filing covers the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. The company was formerly known as Angion Biomedica Corp. and changed its name on February 28, 2014.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.
Risk Assessment
Risk Level: medium — Changes in board and officer composition can indicate internal shifts that may impact future performance.
Key Players & Entities
- Elicio Therapeutics, Inc. (company) — Registrant
- Angion Biomedica Corp. (company) — Former company name
- March 21, 2025 (date) — Effective date of reported changes
- March 24, 2025 (date) — Filing date of the 8-K
FAQ
What specific changes were made regarding directors or officers?
The filing indicates the departure of directors or certain officers, the election of directors, and the appointment of certain officers, effective March 21, 2025.
What is the effective date of the reported changes?
The earliest event reported is dated March 21, 2025.
When was this Form 8-K filed?
This Form 8-K was filed on March 24, 2025.
What was Elicio Therapeutics, Inc. formerly known as?
Elicio Therapeutics, Inc. was formerly known as Angion Biomedica Corp.
When did the company change its name from Angion Biomedica Corp.?
The date of the name change was February 28, 2014.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 24, 2025 regarding Elicio Therapeutics, Inc. (ELTX).